UV-Visible Spectrophotometric Method for Complexes Stoichiometry between Zn(II), Mg(II), Cd(II), Ca(II) and Cu(II) with Clonidine Hydrochloride

被引:0
作者
Karaderi, Serap [1 ]
Bayraktar, Sena [1 ]
Mazi, Caner [1 ]
机构
[1] Marmara Univ, Fac Pharm, Dept Analyt Chem, TR-34668 Istanbul, Turkey
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES | 2021年 / 10卷 / 03期
关键词
Clonidine hydrochloride; Cadmium(II); Copper(II); Zinc(II); Calcium(II); Magnesium(II); STABILITY-CONSTANTS;
D O I
10.51847/fXSBoyPF7i
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, an accurate, rapid, and simple, UV-Visible spectrophotometric method was developed for determining complexes stoichiometry of Zn(II)-clonidine hydrochloride, Mg(II)-clonidine hydrochloride, Cd(II)-clonidine hydrochloride, Ca(II)-clonidine hydrochloride, and Cu(II)-clonidine hydrochloride. The spectra of the complexes formed between clonidine hydrochloride with Zn (II), Mg (II), Cd (II), Ca (II), and Cu (II) cations were determined at 190-400 nm and the stoichiometry of the complexes formed between clonidine hydrochloride with the mentioned metal cations was determined at maximum wavelength using the mole ratio method. The stoichiometry of Cu2+-clonidine hydrochloride, Cd(II)-clonidine hydrochloride, Zn(II)-clonidine hydrochloride, and Mg(II)-clonidine hydrochloride were calculated as 1:1, but Ca(II)-clonidine hydrochloride, the complex was 1:2. The recovery was 100.8% for clonidine hydrochloride. The LOQ and LOD were 0.003 and 0.0028 mu g/mL, respectively for clonidine hydrochloride. The interaction between clonidine hydrochloride with Cu2+, Ca2+ Cd2+, Mg2+, and Zn2+ were evaluated using the UV-vis spectrophotometric method, and reasonable results were obtained.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 13 条
[1]  
Bergendahl HT., 2002, Clonidine in paediatric anaesthesia: Pharmacokinetic and pharmacodynamic aspects
[2]   Stability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system [J].
Classen, AM ;
Wimbish, GH ;
Kupiec, TC .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 28 (06) :603-611
[3]  
Corciova A, 2016, IRAN J PHARM RES, V15, P149
[4]  
Danafar H., 2015, Pharmaceutical and biomedical research, V1, P48, DOI DOI 10.18869/ACADPUB.PBR.1.4.48
[5]  
Dilek M, 2017, J NEPHROLSPEC TOP, V10, P1
[6]   CLONIDINE HYDROCHLORIDE - REVIEW OF PHARMACOLOGIC AND CLINICAL ASPECTS [J].
HOUSTON, MC .
PROGRESS IN CARDIOVASCULAR DISEASES, 1981, 23 (05) :337-350
[7]  
Karaderi S, 2020, INT J PHARM RES ALLI, V9, P121
[8]  
Karaderi S, 2019, INT J PHARM RES ALLI, V8, P1
[9]  
Karakoc EV, 2012, SMYRNA TIP DERGISI, P62
[10]  
Khushboom G, 2014, INT B DRUG RES, V6, P105